leisure time -WSS

leisure time

author：focus 2025-08-06 05:21:53 - browse：97

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： What to expect at HLTH 2023, the health care industry conference

WSS

Why Charlie Gard's case is so disturbing to Americans

Phenylephrine and the overlooked value of the placebo effect

A virus, fished out of a lake, may have saved a man’s life

AI can decode, harness the power of the humane immune system

In Spain, a hospital brews its own CAR

Medicare Advantage beneficiaries sue Humana over algorithm use

Wikipedia

leisure time

explore

Tori Bowie and the unacceptable rates of Black maternal death

Colorectal cancer study finds potential in overlooked immune cell

Trump demands the U.S. pay no more for drugs than other countries … again

What to expect at HLTH 2023, the health care industry conference

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Hospitals owned by private equity see complications spike 25%

23andMe had bad news about my health. I wish a person had delivered it

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Sports medicine is finally prioritizing gender equality

Drinking less cuts risk of oral cavity, esophageal cancer: Report

focus

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Violet CEO on training clinicians to promote more inclusive care

A virus, fished out of a lake, may have saved a man’s life

VC firm General Catalyst wants to buy a health system

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

When women are denied an abortion, their children fare worse than peers

explore

hotspot

entertainment

knowledge